Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
J. Clin. Oncol 2023 Jul 19;[EPub Ahead of Print], M Ingham, JB Allred, L Chen, B Das, B Kochupurakkal, K Gano, S George, S Attia, MA Burgess, M Seetharam, SA Boikos, N Bui, JL Chen, JL Close, GM Cote, PH Thaker, SP Ivy, S Bose, A D'Andrea, A Marino-Enriquez, GI Shapiro, GK SchwartzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.